Zacks.com on MSN9h
TNDM Stock Likely to Gain From Innovation Amid Competition
Tandem Diabetes TNDM is gaining from continued product innovations. Yet, ongoing macroeconomic challenges and tough ...
TNDM Stock Likely to Benefit From the t:slim X2-Lyumjev Offering in EU
The t:slim X2 pump is currently cleared for use with Humalog and Novolog/NovoRapid U-100 insulins globally, and Admelog/Insulin lispro Sanofi and Trurapi/Insulin aspart Sanofi U-100 insulins in Canada ...
thecardiologyadvisor.com10h
Continuous Glucose Monitoring Enhances Inpatient Diabetes Care
Continuous glucose monitoring, compared with fingerstick tests, was feasible and accurate in an inpatient setting among patients and nurses.
Dexcom, Beyond Type 2 and Retta Establish National Glucose Awareness Week to Close the Glucose Knowledge Gap
DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, in ...
Le Lézard10h
BIOPHYLE LAUNCHING COMMERCIALIZATION TRAINING PROGRAM FOR ARKANSAS LIFE SCIENCE RESEARCHERS
Arkansas and biotech industry leaders?today announced the launch of the Biotech Entrepreneur Training Program. The training program is ...